|
表紙
Full Text:
CiNii
|
|
|
The Pharmaceutical Society of Japan Overseas Membership Application
Full Text:
CiNii
|
|
|
YAKUGAKU ZASSHI(Editorial Board)
Full Text:
CiNii
|
i
|
|
CONTENTS
Full Text:
CiNii
|
ii
|
|
目次
Full Text:
CiNii
|
iii
|
|
Author Index
Full Text:
CiNii
|
iv
|
|
著者索引
Full Text:
CiNii
|
iv
|
|
The Safety Securing and the Safety Monitoring of Herbal Medicines, Finished Herbal Products and Supplements(Symposium Review)
Full Text:
CiNii
|
835-836
|
|
The Safety of Health Foods and Importance of Their Origin(Symposium Review)
Full Text:
CiNii
|
837-838
|
|
Legal Situations of Supplements in the United States and European Union(Symposium Review)
Full Text:
CiNii
|
839-850
|
|
Preparedness Response to Hazard and Toxic Incidents, and Food Terrorism(Symposium Review)
Full Text:
CiNii
|
851-857
|
|
How to Use Medical and Drug Information? The View of Integrated Information Handling(Symposium Review)
Full Text:
CiNii
|
859-866
|
|
Regulatory Sciences in Herbal Medicines and Dietary Supplements(Symposium Review)
Full Text:
CiNii
|
867-880
|
|
Development of Assay Methods for Endogenous Inorganic Sulfur Compounds and Sulfurtransferases and Evaluation of the Physiological Functions of Bound Sulfur
Full Text:
CiNii
|
881-900
|
|
Expressions and Regulations of Renal Sodium-Cotransporters and -Antiporters, and Related-Transport Proteins
Full Text:
CiNii
|
901-917
|
|
Development of Highly Selective and Sensitive Fluorescent and Chemiluminescent Reagents
Full Text:
CiNii
|
919-924
|
|
Application of Text Mining Approach to Pre-education prior to Clinical Practice
Full Text:
CiNii
|
925-931
|
|
Antimutagenic Activity of a Novel Ascorbic Derivative, Disodium Isostearyl 2-O-L-Ascorbyl Phosphate
Full Text:
CiNii
|
933-940
|
|
Pharmacokinetics and Biodistribution of Paclitaxel-loaded Pluronic P105/L101 Mixed Polymeric Micelles
Full Text:
CiNii
|
941-950
|
|
Drug Delivery to the Colon Using a Novel One-Step Dry-Coated Tablets (OSDrC)
Full Text:
CiNii
|
951-957
|
|
Measurement of Amount of Fentanyl Remaining in Used Patches : Investigation of Clinical Factors Affecting the Remaining Amounts in 4 Patients
Full Text:
CiNii
|
959-964
|
|
Evidence Based Quality Management of the Clinical Formulations : Determination of the Expiration Date of the Powdered Medicine Prepared by Grinding Tablets
Full Text:
CiNii
|
965-970
|
|
Analytical Data of Designated Substances (Shitei-Yakubutsu) Controlled by the Pharmaceutical Affairs Law in Japan, Part I : GC-MS and LC-MS
Full Text:
CiNii
|
971-979
|
|
Analytical Data of Designated Substances (Shitei-Yakubutsu) Controlled by the Pharmaceutical Affairs Law in Japan, Part II : Color Test and TLC
Full Text:
CiNii
|
981-987
|
|
YAKUGAKU ZASSHI投稿規定
Full Text:
CiNii
|
A1-A3
|
|
YAKUGAKU ZASSHI Instructions for Authors
Full Text:
CiNii
|
A4-A6
|
|
Welcome to PSJ Web Site
Full Text:
CiNii
|
|
|
裏表紙
Full Text:
CiNii
|
|
